spacer
home > ebr > summer 2017 > strategic advantage
PUBLICATIONS
European Biopharmaceutical Review

Strategic Advantage

Pharmacovigilance (PV) is beginning to touch more aspects of life sciences organisations in the form of additional functions as well as international operations, including affiliates. Overcoming silos and establishing closer collaboration between PV and quality operations is a growing priority and, as circumstances evolve, responsibility for the monitoring of safety and associated systems will have to be shared by an increasingly diverse range of stakeholders.

Quality Rules


One thing the life sciences industry cannot escape is a heightened emphasis on quality as inspections increase. Although this presents certain obstacles, it also prompts companies to put better systems and processes in place – senior management now understands the importance of PV and are beginning to allocate more resources to it.

The conceivable downside is that too much attention on compliance could detract from the real motivation underlying all of this which is, of course, to improve patient safety and public confidence. Two ways of keeping things in clear focus are to get teams working together more readily and to take shared responsibility for making improvements.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Cheryl Key, MBBS, MFPM, is Head of Practice PV Platform Services and Principal Medic at ProductLife Group, with final responsibility for all projects, programmes and engagements in the platform, as well as for day-to-day management of the platform team. She has a medical degree from Charing Cross and Westminster Medical School, UK, a diploma in pharmaceutical medicine, membership of the Royal College of General Practitioners and membership of the Faculty of Pharmaceutical Medicine. Cheryl is also on the Specialist Register at the General Medical Council for Pharmaceutical Medicine and a member of the board of the Faculty of Pharmaceutical Medicine.
spacer
Cheryl Key
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals and Nordic Nanovector have extended partnership for Betalutin® late stage manufacturing for B-cell non-Hodgkin lymphoma (NHL) treatment

The non-Hodgkin lymphoma (NHL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement